Oxidative Stress Promotes Ocular Neovascularization

被引:112
|
作者
Dong, Aling
Xie, Bing
Shen, Jikui
Yoshida, Tsunehiko
Yokoi, Katsutoshi
Hackett, Sean F.
Campochiaro, Peter A. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21287 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; CHOROIDAL NEOVASCULARIZATION; INCREASED EXPRESSION; MODEL; MICE; RANIBIZUMAB; RETINOPATHY; OXIDASE; DRUSEN; VEGF;
D O I
10.1002/jcp.21698
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mice deficient in superoxide dismutase / (Sod I-/- mice) develop many features seen in patients with age-related macular degeneration (AMD) including choroidal neovascularization (NV). We sought to determine if the absence of SOD I contributes to the pro-angiogenic environment in the subretinal space or whether it is completely secondary to other changes in Bruch's membrane and the retinal pigmented epithelium (RPE) that precede the development of choroidal NV. In an ischemic retinopathy model or a transgenic model in which the rhodopsin promoter drives expression of vascular endothelial growth factor (VEGF) in photoreceptor there was significantly more NV in Sod I-/- compared to Sod I+/+ mice. The compromised antioxidant defense system in Sod I-/- mice contributes to the proangiogenic environment, because treatment of Sod I-/- mice with a mixture of antioxidants caused a significant reduction in ischemia-induced retinal NV. Wild-type mice treated with the same antioxidants also showed reduced ischemia-induced retinal NV, reduced VEGF-induced subretinal NV, and reduced choroidal NV at Bruch's membrane rupture sites. These data suggest that reactive oxygen species contribute to several types of ocular NV. This could explain why in the Age-Related Eye Disease Trial, antioxidant treatment reduced conversion from non-neovascular to neovascular AMD and severe vision loss, and suggest that potent antioxidants should be considered for other diseases complicated by ocular NV.
引用
收藏
页码:544 / 552
页数:9
相关论文
共 50 条
  • [31] OCULAR NEOVASCULARIZATION IN CAROTID STENOSIS
    WINTER, R
    GRONEMEYER, U
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1980, 177 (01) : 118 - 118
  • [32] RETINAL NEOVASCULARIZATION AND OCULAR TOXOPLASMOSIS
    GAYNON, MW
    FINE, SL
    STRAHLMAN, ER
    BOLDREY, EE
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1984, 98 (05) : 585 - 589
  • [33] Ocular microbiota promotes pathological angiogenesis and inflammation in sterile injury-driven corneal neovascularization
    Lee, Hyun Ju
    Yoon, Chang Ho
    Kim, Hyeon Ji
    Ko, Jung Hwa
    Ryu, Jin Suk
    Jo, Dong Hyun
    Kim, Jeong Hun
    Kim, Donghyun
    Oh, Joo Youn
    MUCOSAL IMMUNOLOGY, 2022, 15 (06) : 1350 - 1362
  • [34] Gene therapy for ocular neovascularization
    Campochiaro, Peter A.
    CURRENT GENE THERAPY, 2007, 7 (01) : 25 - 33
  • [35] A review on vasohibin and ocular neovascularization
    Xiao-Nan Hu
    Yan Ni
    Jie Luan
    Yu-Zhi Ding
    International Journal of Ophthalmology, 2020, (06) : 1004 - 1008
  • [36] MicroRNAs regulate ocular neovascularization
    Shen, Jikui
    Yang, Xiaoru
    Xie, Bing
    Chen, Yangjian
    Swaim, Mara
    Hackett, Sean F.
    Campochiaro, Peter A.
    MOLECULAR THERAPY, 2008, 16 (07) : 1208 - 1216
  • [37] Ocular neovascularization: Genomic implications
    Higgins, RD
    CURRENT GENOMICS, 2005, 6 (05) : 315 - 318
  • [38] Ocular neovascularization: An epidemiologic review
    Lee, P
    Wang, CC
    Adamis, AP
    SURVEY OF OPHTHALMOLOGY, 1998, 43 (03) : 245 - 269
  • [39] Role of macrophage in ocular neovascularization
    Tu, Yuanyuan
    Luo, Yalu
    Zhao, Qingliang
    Zeng, Yanfeng
    Leng, Kai
    Zhu, Manhui
    HELIYON, 2024, 10 (10)
  • [40] Lipid Signaling in Ocular Neovascularization
    Terao, Ryo
    Kaneko, Hiroki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 22